Sub-Total: $0.00
Emerging Strategies in the Anti–Interleukin-5 Monoclonal Antibody Based Targeted Therapies for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Complimentary
Related products
-
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more -
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more -
Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more
